Similarly, Li et al. [47] found elevated SNHG3 expression in NSCLC, where it inhibits cell proliferation, migration, and invasion while positively regulating SUMO2 through the miR-515-5p/SUMO2 axis. This evidence concerns the gene SNHG3 and non-small cell lung carcinoma.